Islet transplantation with Tegoprubart (AT-1501) immunosupression-based therapy
IRB23-1367
Phase 2 small_molecule active
Quick answer
Islet transplantation with Tegoprubart (AT-1501) immunosupression-based therapy for Type 1 Diabetes Mellitus is a Phase 2 program (small_molecule) at Eledon Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eledon Pharmaceuticals
- Indication
- Type 1 Diabetes Mellitus
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active